MedTrace Logo

Nocturnal Cyclic Enteral Nutrition Infusion Versus Continuous Infusion of Enteral Nutrition

NCT03727165 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-03-13

No results posted yet for this study

Summary

Enteral nutrition is considered the best way to feed those who can´t be fed orally. the standard protocol of administration includes continuous infusion for 24 hours; nonetheless this support is constantly suspended which causes a decrease in the nutrition administered vs the one formulated.

Therefore this randomized clinical trial attempts to compare de standard administration vs. cyclic infusion during night hours measuring the formulated vs the administered volume of enteral nutrition given to the patient.

The control group will be assigned standard 24 hour infusion of enteral nutrition while the experimental group will be assigned cyclic infusion during night hours. The variables include volume formulated, volume given in 24 hours, hours and reasons why the enteral nutrition was suspended, and related complications (abdominal distension, vomiting, and diarrhea).

Conditions

  • Critical Illness
  • Enteral Feeding Intolerance
  • Nutrition Support

Interventions

OTHER

Continuous enteral nutrition infusion

Enteral nutrition administration in continuous infusion during 24 hours per day

OTHER

Cyclic enteral nutrition infusion

Enteral nutrition administration in continuous infusion during 16 hours per day

Sponsors & Collaborators

  • Hospital Universitario San Ignacio

    lead OTHER

Principal Investigators

  • Saul J Rugeles, MD · Hospital Universitario San Ignacio

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-11
Primary Completion
2024-03-12
Completion
2024-03-12

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03727165 on ClinicalTrials.gov